ELAN(Elanco Animal Health Incorporated) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $4.76B | $4.41B | $4.42B | $4.44B | $4.71B |
| 毛利润 | $2.63B | $2.50B | $2.49B | $2.44B | $2.59B |
| 营业利润 | — | — | — | — | — |
| 净利润 | −$483.00M | −$78.00M | −$1.23B | $338.00M | −$232.00M |
| 经营现金流 | $483.00M | $452.00M | $271.00M | $541.00M | $560.00M |
| 自由现金流 | $324.00M | $281.00M | $131.00M | $394.00M | $284.00M |
| 摊薄每股收益 | $-0.99 | $-0.16 | $-2.50 | $0.68 | $-0.47 |